TGF-β promotes tumor progression by inducing epithelial-mesenchymal transition of tumor cells, recruiting immunosuppressive cells like Tregs and MDSCs as well as inhibiting functions of CD8+ T cells (Batlle and Massagué, 2019). This evidence concerns the gene CD8A and neoplasm.